A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infection.
Cell reports. Medicine
View this publicationCell reports. Medicine
View this publicationScience advances
View this publicationCellular immunology
View this publicationJournal of the Endocrine Society
View this publicationFrontiers in immunology
View this publicationClinical immunology (Orlando, Fla.)
View this publicationJAMA
View this publicationAtherosclerosis plus
View this publicationEuropean heart journal
View this publicationeLife
View this publication